The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult ...

Walking is a fundamental activity for maintaining health. While numerous studies have assessed how much people with chronic ...

A Winnipeg woman who was given a life expectancy of six months after cancer spread from her lungs to her brain, liver and ...

New tools, treatment options, and precision medicine developments are leading to better quality of life and survival for ...

Emergency crews pulled nine adults from a sinking sailboat in the choppy waters of the San Francisco bay. Dr. Daniel Ngui, BSc, (P.T.), MD, CFPC, FCFP, Family Physician, discusses What is Chronic ...

Home-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but ...

1 World Health Organization. (2023, November 15). Smoking is the leading cause of chronic obstructive pulmonary disease. World Health Organization. Retrieved November 14, 2024 from https://www.who ...

Emphysema subtypes, identified via CT, may be linked to cardiopulmonary subphenotypes that can help to target cardiac care in early COPD.

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately ...

In vivo platelet activation and related pathways may be linked to small airways disease and pulmonary vascular changes in smokers.

Lung diseases encompass a diverse range of disorders, including Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), ...

Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Market Overview The global interventional pulmonology device market is projected to reach USD 6.2 billion in 2024 and is expected ...